To investigate the effect of atomoxetine hydrochloride in treating adults who have attention deficit hyperactivity disorder with comorbid social anxiety disorder

Inclusion Criteria:

• You must be 18 to 65 years old.
• You must have been diagnosed with attention deficit hyperactivity disorder and social anxiety disorder.
• You must be able to visit the doctor's office at least 8 times over a 16 week period.
• You must agree to participate with all tests and examinations that are required for this study.

Exclusion Criteria:

• You are a woman and pregnant or breastfeeding.
• You presently have an acute or unstable medical illness.
• You have a history of allergic reaction to atomoxetine hydrochloride.
• You are taking medications that are not permitted in this study. Your physician will discuss these with you.
• You have taken part in another clinical research trial within the last 30 days or have received treatment with a drug in the last 30 days that has not received regulatory approval.